Skip to main content
logo
Vivoryon Therapeutics N.V. (AMS:VVY)
Netherlands flag Netherlands · Delayed Price · Currency is EUR
1.130
-0.010 (-0.88%)
Aug 27, 2026, 12:28 PM CET

Vivoryon Therapeutics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
344252212249381
Market Cap Growth
-11.86%-18.93%-75.55%-14.71%-34.70%111.67%
Enterprise Value
313737174225361
Last Close Price
1.141.421.998.1410.3219.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-9.349.349.349.349.34
PS Ratio
----58.61-35.39
PB Ratio
21.578.906.588.079.3923.01
P/TBV Ratio
42.2010.707.408.379.5623.77

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----33.57

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.020.010.000.010.01
Net Debt / Equity Ratio
-1.51-1.17-1.18-1.09-1.00-0.87
Net Debt / EBITDA Ratio
0.350.620.440.990.911.14
Net Debt / FCF Ratio
0.330.650.481.321.211.28
Asset Turnover
-----0.40
Quick Ratio
4.037.206.929.309.353.57
Current Ratio
4.567.687.209.379.404.01
Return on Equity (ROE)
-285.21%-140.45%-120.41%-107.38%-130.77%-59.17%
Return on Assets (ROA)
-80.06%-59.25%-62.22%-57.95%-65.10%-29.48%
Return on Capital Employed (ROCE)
-194.90%-133.40%-212.00%-104.30%-103.60%-65.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-20.05%-21.05%-39.65%-13.36%-11.32%-3.32%
FCF Yield
-21.05%-20.12%-36.97%-10.16%-8.77%-2.96%
Buyback Yield / Dilution
-10.09%-3.53%-3.27%-14.64%-10.10%-0.12%